Recent Company News

• 04:01 PM ET Oct 30, 2025
  

  GENFIT announces intention to voluntarily delist ADs from the Nasdaq (€3.64, 0.00)

• 09:18 AM ET Sep 23, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 04:17 PM ET Sep 22, 2025
  

  GENFIT reports H1 net income (€10.0M) vs year-ago €30.3M - 6-K (€3.29, 0.00)

• 04:11 AM ET May 23, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:54 AM ET Sep 22, 2025
  

  StreetAccount Summary - European pre-market trading update

• 04:17 PM ET Sep 19, 2025
  

  GENFIT to discontinue VS-01 program in ACLF (€3.61, 0.00)

• 06:21 AM ET Aug 19, 2025
  

  HC Wainwright assumes GNFT, VALN

• 04:33 PM ET Aug 18, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 05:14 PM ET Jul 16, 2025
  

  FDA grants orphan drug designation to elafibranor for primary sclerosing cholangitis (PSC) (€105.70, 0.00)